266
Views
2
CrossRef citations to date
0
Altmetric
Case Report

A pediatric case of NF1 and moyamoya syndrome: Neuropsychological evaluation pre- and post-EDAS

&

References

  • Ardila, A. (2013). Cross-cultural neuropsychology. In B. P. Uzzell, M. Ponton, & A. Ardila (Eds.), International Handbook of Cross-Cultural Neuropsychology. Hove, UK: Psychology Press.
  • Beaussart, M.-L., Barbarot, S., Mauger, C., & Roy, A. (2018). Systematic review and meta-analysis of executive functions in preschool and school-age children with neurobibromatosis type 1. Journal of the International Neuropsychological Society, 24(9), 977–994. doi:10.1017/S1355617718000383
  • Beck, J. S., Beck, A. T., Jolly, J. B., & Steer, R. A. (2015). Beck youth inventories – second edition for children and adolescents manual. San Antonio, TX: PsychCorp.
  • Beery, K. E., Buktenica, N. A., & Beery, N. A. (2010). Beery-Buktenica developmental test of visual-motor integration (6th ed.). San Antonio, TX: Pearson.
  • Byrd, D., Arentoft, A., Scheiner, D., Westerveld, M., & Baron, I. S. (2008). State of multicultural neuropsychological assessment in children: Current research issues. Neuropsychological. Neuropsychology Review, 18, 214–222. doi:10.1007/s11065-008-9065-y
  • Cohen, M. (1997). Children’s memory scale (CMS). San Antonio, TX: Pearson.
  • Conners, C. K. (2015). Conners kiddie continuous performance test second edition (K-CPT 2). North Tonawanda, NY: Mhs.
  • Deng, X., Gao, F., Zhang, D., Zhang, Y., Wang, R., Wang, S., … Zhao, J. (2018). Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: A prospective cohort study. Journal of Neurosurgery, 128(5), 1327–1337. doi:10.3171/2016.12.JNS162626
  • Duat-Rodriguez, A., Lechon, F. C., Pino, M. A. L., Fernandez, C. R., & Gonzalez-Gutierrez-Solana, L. (2014). Neurfibromatosis Type 1 associated with moyamoya syndrome in children. Pediatric Neurology, 50, 96–98.
  • Garg, S., Lehtonen, A., Huson, S. M., Emsley, R., Trump, D., Evans, D. E., … Green, J. (2013). Autism and other psychiatric comorbidity in neurofribromatosis type 1: Evidence from a population-based study. Developmental Medicine and Child Neurology, 55, 139–145. doi:10.1111/dmcn.12043
  • Gioia, G. A., Isquith, P. K., Guy, S. C., & Kenworthy, L. (2000). Behavior rating inventory of executive function. Lutz, FL: Par.
  • Guzman, R., Lee, M., Achrol, A., Bell-Stephens, T., Kelly, M., Do, H. M., … Steinberg, G. K. (2009). Clinical outcome after 450 revascularization procedures for moyamoya disease. Journal of Neurosurgery, 111(5), 927–935. doi:10.3171/2009.4.JNS081649
  • Hamilton, S. J., & Friedman, J. M. (2000). Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clinical Genetics, 58(5), 341–344. doi:10.1034/j.1399-0004.2000.580501.x
  • Hyman, S. L., Shores, E. A., & North, K. N. (2005). The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology, 65(7), 1037–1044. doi:10.1212/01.wnl.0000179303.72345.ce
  • Hyman, S. L., Shores, E. A., & North, K. N. (2006). Learning disabilities in children with neurofibromatosis type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine and Child Neurology, 48, 973–977. doi:10.1111/j.1469-8749.2006.tb01268.x
  • Kaas, B., Huisman, T. A. G., Tekes, A., Bergner, A., Blakeley, J. O., & Jordan, L. C. (2013). Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type I. Journal of Child Neurology, 28(5), 561–569. doi:10.1177/0883073812448531
  • Kim, S.-K., Cho, B.-K., Phi, J. H., Lee, J. Y., Chae, J. H., Kim, K. J., … Wang, K.-C. (2010). Pediatric moyamoya disease: An analysis of 410 consecutive cases. Annals of Neurology, 68(1), 92–101. doi:10.1002/ana.21981
  • Koc, F., Yerdelen, D., & Koc, Z. (2008). Neurofibromatosis type 1 association with moyamoya disease. International Journal of Neuroscience, 118(8), 1157–1163. doi:10.1080/00207450801898279
  • Korkman, M., Kirk, U., & Kemp, S. (2007). NEPSY-II clinical and interpretive manual (2nd edition). San Antonio, TX: Pearson.
  • Kronenburg, A., van den Berg, E., van Schooneveld, M. M., Braun, K. P. J., Calviere, L., van der Zwan, A., … Klijn, C. J. M. (2018). Cognitive functions in children and adults with moyamoya vasculopathy: A systematic review and meta-analysis. Journal of Stroke, 20(3), 332–341. doi:10.5853/jos.2018.01550
  • Kuroda, S., & Houkin, K. (2008). Moyamoya disease: Current concepts and future perspectives. The Lancet Neurology, 7(11), 1056–1066. doi:10.1016/S1474-4422(08)70240-0
  • Lafayette Instrument. (2003). Grooved pegboard test user instructions. Lafayette, IN: Lafayette Instrument.
  • Lee, J. Y., Phi, J. H., Wang, K.-C., Cho, B.-K., Shin, M.-S., & Kim, S.-K. (2011). Neurocognitive profiles of children with moyamoya disease before and after surgical intervention. Cerebrovascular Diseases, 31(3), 230–237. doi:10.1159/000321901
  • Lehtonen, A., Howie, E., Trump, D., & Hudson, S. M. (2013). Behaviour in children with neurofibromatosis type 1: Cognition, executive function, attention, emotion, and social competence. Developmental Medicine and Child Neurology, 55, 111–125. doi:10.1111/j.1469-8749.2012.04399.x
  • Martin, N. A., & Brownell, R. (2011). Receptive and expressive one-word picture vocabulary tests, fourth edition (ROWPVT-4, EOWPVT-4). San Antonio, TX: Pearson.
  • Muñoz-Sandoval, A. F., Woodcock, R. W., McGrew, K., & Mather, N. (2009). Batería III Woodcock-Muñoz. Itasca, IL: Riverside Publishing.
  • Phi, J. H., Wang, K.-C., Lee, J. Y., & Kim, S.-K. (2015). Moyamoya syndrome: A window of moyamoya disease. Journal of Korean Neurosurgical Society, 57(6), 408–414. doi:10.3340/jkns.2015.57.6.408
  • Plasschaert, E., Van Eylen, L., Descheemaeker, M.-J., Noens, I., Legius, E., & Steyaert, J. (2016). Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 171 B, 348–362. doi:10.1002/ajmg.b.32414
  • Pride, N. A., Payne, J. M., & North, K. N. (2012). The impact of ADHD on the cognitive and academic functioning of children with NF1. Developmental Neuropsychology, 37(7), 590–600. doi:10.1080/87565641.2012.695831
  • Reynolds, C. R., & Kamphaus, R. W. (2015). Behavior assessment system for children (3rd ed.). San Antonio, TX: Pearson.
  • Rosser, T. L., Vezina, G., & Packer, R. J. (2005). Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology, 64(3), 553–555. doi:10.1212/01.WNL.0000150544.00016.69
  • Scott, R. M., & Smith, E. R. (2009). Moyamoya disease and moyamoya syndrome. The New England Journal of Medicine, 360(12), 1226–1236. doi:10.1056/NEJMra0804622
  • Templer, A. K., Titus, J. B., & Gutmann, D. H. (2013). A neuropsychological perspective on attention problems in neurofibromatosis type I. Journal of Attention Disorders, 17, 489–496. doi:10.1177/1087054711433422
  • Tombaugh, T. N. (1996). Test of memory malingering: TOMM. North Tonawanda, New York, NY: Mhs.
  • Tsipi, M., Poulou, M., Fylaktou, I., Kosma, K., Tsoutsou, E., Pons, M.-R, … Tzetis, M. (2018). Phenotypic expression of a spectrum of neurofibromatosis type 1 (NF1) mutations identified through NGS and MLPA. Journal of Neurological Sciences, 395, 95–105.
  • Ulate-Campos, A., & Fernandez, I. S. (2017). Cognitive and behavioral comorbidities: An unwanted effect of antiepileptic drugs in children. Seminars in Pediatric Neurology, 24(4), 320–330. doi:10.1016/j.spen.2017.10.011
  • Vandenbroucke, L., Verschueren, K., & Baeyens, D. (2017). The development of executive functioning across the transition to first grade and its predictive value for academic achievement. Learning and Instruction, 49, 103–112. doi:10.1016/j.learninstruc.2016.12.008
  • Vargiami, E., Sapountzi, E., Samakovitis, D., Batzios, S., Kyriazi, M., Anastasiou, A., … Zaferiou, D. (2014). Moyamoya syndrome and neurofibromatosis type 1. Italian Journal of Pediatrics, 40, 59–64. doi:10.1186/1824-7288-40-59
  • Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQL: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Medical Care, 39(8), 800–812. doi:10.1097/00005650-200108000-00006
  • Wang, C., Zhao, M., Wang, J., Wang, S., Zhang, D., Wang, K., … Zhao, J. (2018). Encephaloduroarteriosynangiosis for pediatric moyamoya disease: A single-center experience with 67 cases in China. Journal of Child Neurology, 33(14), 901–908. doi:10.1177/0883073818798515
  • Wechsler, D. (2009). Wechsler individual achievement test – third edition (WIAT-III). San Antonio, TX: Pearson.
  • Wechsler, D. (2012). Wechsler preschool and primary scale of intelligence - fourth edition San Antonio, TX: The Psychological Corporation.
  • Wechsler, D. (2014). Wechsler intelligence scale for children – fifth edition: Administration and scoring manual. Bloomington, MN: PsychCorp.
  • Weinberg, D. G., Rahme, R. J., Aoun, S. G., Batjer, H. H., & Bendok, B. R. (2011). Moyamoya disease: Functional and neurocognitive outcomes in the pediatric and adult populations. Neurosurgical Focus, 30(6), E21– 7. doi:10.3171/2011.3.FOCUS1150

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.